2glg

From Proteopedia

Revision as of 09:08, 21 November 2007 by OCA (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search

2glg

Drag the structure with the mouse to rotate

NMR structure of the [L23,A24]-sCT mutant

Overview

Salmon calcitonin (sCT) forms an amphipathic helix in the region 9-19, with the C-terminal decapeptide interacting with the helix (Amodeo, P., Motta, A., Strazzullo, G., Castiglione Morelli, M. A. (1999) J. Biomol., NMR 13, 161-174). To uncover the structural requirements for the hormone, bioactivity, we investigated several sCT analogs. They were designed so as, to alter the length of the central helix by removal and/or replacement of, flanking residues and by selectively mutating or deleting residues inside, the helix. The helix content was assessed by circular dichroism and NMR, spectroscopies; the receptor binding affinity in human breast cancer cell, line T 47D and the in vivo hypocalcemic activity were also evaluated. In, particular, by NMR spectroscopy and molecular dynamics calculations we, studied Leu(23),Ala(24)-sCT in which Pro(23) and Arg(24) were replaced by, helix inducing residues. Compared with sCT, it assumes a longer, amphipathic alpha-helix, with decreased binding affinity and one-fifth of, the hypocalcemic activity, therefore supporting the idea of a relationship, between a definite helix length and bioactivity. From the analysis of, other sCT mutants, we inferred that the correct helix length is located in, the 9-19 region and requires long range interactions and the presence of, specific regions of residues within the sequence for high binding affinity, and hypocalcemic activity. Taken together, the structural and biological, data identify well defined structural parameters of the helix for sCT, bioactivity.

About this Structure

2GLG is a Single protein structure of sequence from [1] with NH2 as ligand. Full crystallographic information is available from OCA.

Reference

Structural determinants of salmon calcitonin bioactivity: the role of the Leu-based amphipathic alpha-helix., Andreotti G, Mendez BL, Amodeo P, Morelli MA, Nakamuta H, Motta A, J Biol Chem. 2006 Aug 25;281(34):24193-203. Epub 2006 Jun 9. PMID:16766525

Page seeded by OCA on Wed Nov 21 11:15:37 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools